Roy S
former DC ME/CFS lobbyist
- Messages
- 1,376
- Location
- Illinois, USA
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
!!! One person who self-experimented died!Ron Davis himself issues a big warning on not trying to manipulate your own cellular tryptophan. You could give yourself brain damage or die. They think there could be an easy cure but they want to test it properly and are very worried about patients hurting themselves.
I believe NAD has a short half life. So that could cause a large variance due to processing differences.Wild variance (and I mean wild, check out the graphs below) obscured a distribution that was not really very different.
Should we be losing our minds with excitement? because I think I am.
The role of tryptophan in fatigue in different conditions of stress.
Review article
Castell LM, et al. Adv Exp Med Biol. 1999.
Authors
Castell LM1, Yamamoto T, Phoenix J, Newsholme EA.
Author information
1
University Department of Biochemistry, Oxford, UK. cat@bioch.ox.ac.uk
Citation
Adv Exp Med Biol. 1999;467:697-704.
Abstract
Tryptophan is the precursor for the neurotransmitter 5-hydroxytryptamine (5-HT), which is involved in fatigue and sleep. It is present in bound and free from in the blood, where the concentration is controlled by albumin binding to tryptophan. An increase in plasma free tryptophan leads to an increased rate of entry of tryptophan into the brain. This should lead to a higher level of 5-HT which may cause central fatigue. Central fatigue is implicated in clinical conditions such as chronic fatigue syndrome and post-operative fatigue. Increased plasma free tryptophan leads to an increase in the plasma concentration ratio of free tryptophan to the branched chain amino acids (BCAA) which compete with tryptophan for entry into the brain across the blood-brain barrier. The plasma concentrations of these amino acids were measured in chronic fatigue syndrome patients (CFS) before and after exercise (Castell et al., 1998), and in patients undergoing major surgery (Yamamoto et al., 1997). In the CFS patients, the pre-exercise concentration of plasma free tryptophan was higher than in controls (p < 0.05) but did not change during or after exercise. This might indicate an abnormally high level of brain 5-HT in CFS patients leading to persistent fatigue. In the control group, plasma free tryptophan was increased after maximal exercise (p < 0.001), returning towards baseline levels 60 min later. The apparent failure of the CFS patients to change the plasma free tryptophan concentration or the free tryptophan/BCAA ratio during exercise may indicate increased sensitivity of brain 5-HT receptors, as has been demonstrated in other studies (Cleare et al., 1995). In post-operative recovery after major surgery plasma free tryptophan concentrations were markedly increased compared with baseline levels; the plasma free tryptophan/BCAA concentration ratio was also increased after surgery. Plasma albumin concentrations were decreased after surgery: this may account for the increase in plasma free tryptophan levels. Provision of BCAA has improved mental performance in athletes after endurance exercise (Blomstrand et al., 1995, 1997). It is suggested that BCAA supplementation may help to counteract the effects of an increase in plasma free tryptophan, and may thus improve the status of patients during or after some clinically stressful conditions.
I believe it's more complicated than supplementation. He said the IDO1 route is inhibited and needs to be activated.. he also mentioned a cancer drug. Could it be Indoximod? My guess is that he's theorizing a short trial of a drug that activates the IDO1 gene could fix the cellular imbalance between tryptophan and kynurenine & change the expression of the gene.
https://www.sciencedirect.com/science/article/pii/S2452336417300201
One is to supplement with kynurenine;
In that sense the finding may simply be due to poor matching between patients and controls.
I think 'quiet hope' might be appropriate right now
But you're right, he sure didn't skimp on details
B
That just doesn't sound like something that Dr. Phair, Dr. Davis or anyone on their team would miss. They said it themselves that it needs more testing, and it might turn out to be a fluke, but forgetting to match controls properly? I don't think so.
@Murph - Did you understand Ron's explanation of how this relates to ATP production? If so, can you tie that in with an explanation like the one above that is easily digested?